Publications (104) Juan José Gavira Gómez publications

filter_list

2024

  1. Clinical impact of remote heart failure management using the multiparameter ICD HeartLogic alert

    Revista Espanola de Cardiologia, Vol. 77, Núm. 12, pp. 1008-1017

  2. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study

    Revista Espanola de Cardiologia

2023

  1. Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p.Ser43Asn mutation in the TTR gene

    Stem Cell Research, Vol. 71

  2. Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure

    Journal of Personalized Medicine, Vol. 13, Núm. 7

  3. Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR

    International Journal of Cardiovascular Imaging, Vol. 39, Núm. 9, pp. 1765-1774

  4. Systemic lupus erythematosus myocarditis after COVID-19 vaccination

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 114-116

2022

  1. A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

    Cancers, Vol. 14, Núm. 12

  2. Fabrication of human myocardium using multidimensional modelling of engineered tissues

    Biofabrication, Vol. 14, Núm. 4

  3. Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis

    JACC: Cardiovascular Imaging, Vol. 15, Núm. 11, pp. 1883-1896

  4. Remote heart failure management using the HeartLogic algorithm. RE-HEART registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 9, pp. 710-717

2021

  1. Clinical Profile and Prognosis of a Real-World Cohort of Patients With Moderate or Severe Cancer Therapy-Induced Cardiac Dysfunction

    Frontiers in Cardiovascular Medicine, Vol. 8

  2. Long-term prognostic value of coronary CTA in orthotopic heart transplant recipients

    American Journal of Roentgenology, Vol. 216, Núm. 5, pp. 1216-1221

  3. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis

    Journal of the American College of Cardiology, Vol. 77, Núm. 12, pp. 1503-1516

  4. Preclinical evaluation of the safety and immunological action of allogeneic ADSC-collagen scaffolds in the treatment of chronic ischemic cardiomyopathy

    Pharmaceutics, Vol. 13, Núm. 8

  5. Surgical resection of a transcatheter valve after 8 years of implantation and replacement by aortic bioprosthesis

    Cirugia Cardiovascular, Vol. 28, Núm. 6, pp. 353-356

  6. Valor de la resonancia magnética cardiaca en la coexistencia de TakoTsubo y enfermedad arterial coronaria.: ¿Una coincidencia significativa?

    Revista de Ecocardiografía práctica y otras Técnicas de Imagen Cardíaca (RETIC), Vol. 4, Núm. 2, pp. 26-28

2020

  1. Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering

    Frontiers in Bioengineering and Biotechnology, Vol. 8

  2. Diagnóstico por imagen de la disección arterial coronaria espontánea

    Revista de Ecocardiografía práctica y otras Técnicas de Imagen Cardíaca (RETIC), Vol. 3, Núm. 2, pp. 14-17

  3. Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  4. Expert consensus on multidisciplinary management and integrated approaches in heart failure. Continuity of care from hospital discharge to primary care

    Revista Espanola de Cardiologia Suplementos, Vol. 20, pp. 3-12